Global and United States Total Parenteral Nutrition (TPN) Solution Market Report & Forecast 2022-2028

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Market Analysis and Insights: Global and United States Total Parenteral Nutrition (TPN) Solution Market
This report focuses on global and United States Total Parenteral Nutrition (TPN) Solution market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Total Parenteral Nutrition (TPN) Solution market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Amino Acid-Dextrose Solution accounting for % of the Total Parenteral Nutrition (TPN) Solution global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospital was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Total Parenteral Nutrition (TPN) Solution market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period 2022-2028.

Global Total Parenteral Nutrition (TPN) Solution Scope and Market Size
Total Parenteral Nutrition (TPN) Solution market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Total Parenteral Nutrition (TPN) Solution market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Total Parenteral Nutrition (TPN) Solution market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    Amino Acid-Dextrose Solution
    Lipid Emulsions Solution

Segment by Application
    Hospital
    Home

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
        Colombia
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Eurofarma
    Corporacion De Laboratorios Farmaceuticos
    Baxter International Inc.
    Kelun Pharma
    B. Braun
    Fresenius
    Teva Pharmaceutical Industries
    Pfizer (Hospira)
    Ostuka Pharmaceutical
    Laboratorios Biogalenic
    Laboratorios Finlay
    Grifols International
    Fresenius Kabi
    Sichuan Kelun Pharmaceutical

 1 Study Coverage
    1.1 Total Parenteral Nutrition (TPN) Solution Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Total Parenteral Nutrition (TPN) Solution Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Total Parenteral Nutrition (TPN) Solution Market Size for the Year 2017-2028
        1.2.2 Global Total Parenteral Nutrition (TPN) Solution Market Size for the Year 2017-2028
    1.3 Total Parenteral Nutrition (TPN) Solution Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Total Parenteral Nutrition (TPN) Solution in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Total Parenteral Nutrition (TPN) Solution Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Total Parenteral Nutrition (TPN) Solution Market Dynamics
        1.4.1 Total Parenteral Nutrition (TPN) Solution Industry Trends
        1.4.2 Total Parenteral Nutrition (TPN) Solution Market Drivers
        1.4.3 Total Parenteral Nutrition (TPN) Solution Market Challenges
        1.4.4 Total Parenteral Nutrition (TPN) Solution Market Restraints
    1.5 Study Objectives
    1.6 Years Considered

 2 Total Parenteral Nutrition (TPN) Solution by Type
    2.1 Total Parenteral Nutrition (TPN) Solution Market Segment by Type
        2.1.1 Amino Acid-Dextrose Solution
        2.1.2 Lipid Emulsions Solution
    2.2 Global Total Parenteral Nutrition (TPN) Solution Market Size by Type (2017, 2022 & 2028)
    2.3 Global Total Parenteral Nutrition (TPN) Solution Market Size by Type (2017-2028)
    2.4 United States Total Parenteral Nutrition (TPN) Solution Market Size by Type (2017, 2022 & 2028)
    2.5 United States Total Parenteral Nutrition (TPN) Solution Market Size by Type (2017-2028)

 3 Total Parenteral Nutrition (TPN) Solution by Application
    3.1 Total Parenteral Nutrition (TPN) Solution Market Segment by Application
        3.1.1 Hospital
        3.1.2 Home
    3.2 Global Total Parenteral Nutrition (TPN) Solution Market Size by Application (2017, 2022 & 2028)
    3.3 Global Total Parenteral Nutrition (TPN) Solution Market Size by Application (2017-2028)
    3.4 United States Total Parenteral Nutrition (TPN) Solution Market Size by Application (2017, 2022 & 2028)
    3.5 United States Total Parenteral Nutrition (TPN) Solution Market Size by Application (2017-2028)

 4 Global Total Parenteral Nutrition (TPN) Solution Competitor Landscape by Company
    4.1 Global Total Parenteral Nutrition (TPN) Solution Market Size by Company
        4.1.1 Top Global Total Parenteral Nutrition (TPN) Solution Companies Ranked by Revenue (2021)
        4.1.2 Global Total Parenteral Nutrition (TPN) Solution Revenue by Player (2017-2022)
    4.2 Global Total Parenteral Nutrition (TPN) Solution Concentration Ratio (CR)
        4.2.1 Total Parenteral Nutrition (TPN) Solution Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Total Parenteral Nutrition (TPN) Solution in 2021
        4.2.3 Global Total Parenteral Nutrition (TPN) Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Total Parenteral Nutrition (TPN) Solution Headquarters, Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Total Parenteral Nutrition (TPN) Solution Headquarters and Area Served
        4.3.2 Global Total Parenteral Nutrition (TPN) Solution Companies Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Total Parenteral Nutrition (TPN) Solution Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Total Parenteral Nutrition (TPN) Solution Market Size by Company
        4.5.1 Top Total Parenteral Nutrition (TPN) Solution Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Total Parenteral Nutrition (TPN) Solution Revenue by Players (2020, 2021 & 2022)

 5 Global Total Parenteral Nutrition (TPN) Solution Market Size by Region
    5.1 Global Total Parenteral Nutrition (TPN) Solution Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Total Parenteral Nutrition (TPN) Solution Market Size by Region (2017-2028)
        5.2.1 Global Total Parenteral Nutrition (TPN) Solution Market Size by Region: 2017-2022
        5.2.2 Global Total Parenteral Nutrition (TPN) Solution Market Size by Region (2023-2028)

 6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Total Parenteral Nutrition (TPN) Solution Market Size YoY Growth 2017-2028
        6.1.2 North America Total Parenteral Nutrition (TPN) Solution Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 United States
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Total Parenteral Nutrition (TPN) Solution Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Total Parenteral Nutrition (TPN) Solution Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 China Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
    6.3 Europe
        6.3.1 Europe Total Parenteral Nutrition (TPN) Solution Market Size YoY Growth 2017-2028
        6.3.2 Europe Total Parenteral Nutrition (TPN) Solution Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Total Parenteral Nutrition (TPN) Solution Market Size YoY Growth 2017-2028
        6.4.2 Latin America Total Parenteral Nutrition (TPN) Solution Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
        6.4.6 Colombia
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Total Parenteral Nutrition (TPN) Solution Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Total Parenteral Nutrition (TPN) Solution Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE

 7 Company Profiles
    7.1 Eurofarma
        7.1.1 Eurofarma Company Details
        7.1.2 Eurofarma Business Overview
        7.1.3 Eurofarma Total Parenteral Nutrition (TPN) Solution Introduction
        7.1.4 Eurofarma Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022)
        7.1.5 Eurofarma Recent Development
    7.2 Corporacion De Laboratorios Farmaceuticos
        7.2.1 Corporacion De Laboratorios Farmaceuticos Company Details
        7.2.2 Corporacion De Laboratorios Farmaceuticos Business Overview
        7.2.3 Corporacion De Laboratorios Farmaceuticos Total Parenteral Nutrition (TPN) Solution Introduction
        7.2.4 Corporacion De Laboratorios Farmaceuticos Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022)
        7.2.5 Corporacion De Laboratorios Farmaceuticos Recent Development
    7.3 Baxter International Inc.
        7.3.1 Baxter International Inc. Company Details
        7.3.2 Baxter International Inc. Business Overview
        7.3.3 Baxter International Inc. Total Parenteral Nutrition (TPN) Solution Introduction
        7.3.4 Baxter International Inc. Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022)
        7.3.5 Baxter International Inc. Recent Development
    7.4 Kelun Pharma
        7.4.1 Kelun Pharma Company Details
        7.4.2 Kelun Pharma Business Overview
        7.4.3 Kelun Pharma Total Parenteral Nutrition (TPN) Solution Introduction
        7.4.4 Kelun Pharma Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022)
        7.4.5 Kelun Pharma Recent Development
    7.5 B. Braun
        7.5.1 B. Braun Company Details
        7.5.2 B. Braun Business Overview
        7.5.3 B. Braun Total Parenteral Nutrition (TPN) Solution Introduction
        7.5.4 B. Braun Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022)
        7.5.5 B. Braun Recent Development
    7.6 Fresenius
        7.6.1 Fresenius Company Details
        7.6.2 Fresenius Business Overview
        7.6.3 Fresenius Total Parenteral Nutrition (TPN) Solution Introduction
        7.6.4 Fresenius Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022)
        7.6.5 Fresenius Recent Development
    7.7 Teva Pharmaceutical Industries
        7.7.1 Teva Pharmaceutical Industries Company Details
        7.7.2 Teva Pharmaceutical Industries Business Overview
        7.7.3 Teva Pharmaceutical Industries Total Parenteral Nutrition (TPN) Solution Introduction
        7.7.4 Teva Pharmaceutical Industries Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022)
        7.7.5 Teva Pharmaceutical Industries Recent Development
    7.8 Pfizer (Hospira)
        7.8.1 Pfizer (Hospira) Company Details
        7.8.2 Pfizer (Hospira) Business Overview
        7.8.3 Pfizer (Hospira) Total Parenteral Nutrition (TPN) Solution Introduction
        7.8.4 Pfizer (Hospira) Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022)
        7.8.5 Pfizer (Hospira) Recent Development
    7.9 Ostuka Pharmaceutical
        7.9.1 Ostuka Pharmaceutical Company Details
        7.9.2 Ostuka Pharmaceutical Business Overview
        7.9.3 Ostuka Pharmaceutical Total Parenteral Nutrition (TPN) Solution Introduction
        7.9.4 Ostuka Pharmaceutical Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022)
        7.9.5 Ostuka Pharmaceutical Recent Development
    7.10 Laboratorios Biogalenic
        7.10.1 Laboratorios Biogalenic Company Details
        7.10.2 Laboratorios Biogalenic Business Overview
        7.10.3 Laboratorios Biogalenic Total Parenteral Nutrition (TPN) Solution Introduction
        7.10.4 Laboratorios Biogalenic Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022)
        7.10.5 Laboratorios Biogalenic Recent Development
    7.11 Laboratorios Finlay
        7.11.1 Laboratorios Finlay Company Details
        7.11.2 Laboratorios Finlay Business Overview
        7.11.3 Laboratorios Finlay Total Parenteral Nutrition (TPN) Solution Introduction
        7.11.4 Laboratorios Finlay Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022)
        7.11.5 Laboratorios Finlay Recent Development
    7.12 Grifols International
        7.12.1 Grifols International Company Details
        7.12.2 Grifols International Business Overview
        7.12.3 Grifols International Total Parenteral Nutrition (TPN) Solution Introduction
        7.12.4 Grifols International Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022)
        7.12.5 Grifols International Recent Development
    7.13 Fresenius Kabi
        7.13.1 Fresenius Kabi Company Details
        7.13.2 Fresenius Kabi Business Overview
        7.13.3 Fresenius Kabi Total Parenteral Nutrition (TPN) Solution Introduction
        7.13.4 Fresenius Kabi Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022)
        7.13.5 Fresenius Kabi Recent Development
    7.14 Sichuan Kelun Pharmaceutical
        7.14.1 Sichuan Kelun Pharmaceutical Company Details
        7.14.2 Sichuan Kelun Pharmaceutical Business Overview
        7.14.3 Sichuan Kelun Pharmaceutical Total Parenteral Nutrition (TPN) Solution Introduction
        7.14.4 Sichuan Kelun Pharmaceutical Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022)
        7.14.5 Sichuan Kelun Pharmaceutical Recent Development

 8 Research Findings and Conclusion

 9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Total Parenteral Nutrition (TPN) Solution Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Total Parenteral Nutrition (TPN) Solution Market Trends
    Table 3. Total Parenteral Nutrition (TPN) Solution Market Drivers
    Table 4. Total Parenteral Nutrition (TPN) Solution Market Challenges
    Table 5. Total Parenteral Nutrition (TPN) Solution Market Restraints
    Table 6. Global Total Parenteral Nutrition (TPN) Solution Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Total Parenteral Nutrition (TPN) Solution Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Total Parenteral Nutrition (TPN) Solution Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Total Parenteral Nutrition (TPN) Solution Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Total Parenteral Nutrition (TPN) Solution Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Total Parenteral Nutrition (TPN) Solution Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Total Parenteral Nutrition (TPN) Solution Revenue Share by Player, 2017-2022
    Table 13. Global Total Parenteral Nutrition (TPN) Solution Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Total Parenteral Nutrition (TPN) Solution by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Total Parenteral Nutrition (TPN) Solution as of 2021)
    Table 15. Top Players of Total Parenteral Nutrition (TPN) Solution in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Total Parenteral Nutrition (TPN) Solution Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Total Parenteral Nutrition (TPN) Solution Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Total Parenteral Nutrition (TPN) Solution Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Total Parenteral Nutrition (TPN) Solution Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Total Parenteral Nutrition (TPN) Solution Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Total Parenteral Nutrition (TPN) Solution Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Total Parenteral Nutrition (TPN) Solution Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Total Parenteral Nutrition (TPN) Solution Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Total Parenteral Nutrition (TPN) Solution Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Total Parenteral Nutrition (TPN) Solution Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Total Parenteral Nutrition (TPN) Solution Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Total Parenteral Nutrition (TPN) Solution Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Eurofarma Company Details
    Table 31. Eurofarma Business Overview
    Table 32. Eurofarma Total Parenteral Nutrition (TPN) Solution Product
    Table 33. Eurofarma Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022) & (US$ Million)
    Table 34. Eurofarma Recent Development
    Table 35. Corporacion De Laboratorios Farmaceuticos Company Details
    Table 36. Corporacion De Laboratorios Farmaceuticos Business Overview
    Table 37. Corporacion De Laboratorios Farmaceuticos Total Parenteral Nutrition (TPN) Solution Product
    Table 38. Corporacion De Laboratorios Farmaceuticos Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022) & (US$ Million)
    Table 39. Corporacion De Laboratorios Farmaceuticos Recent Development
    Table 40. Baxter International Inc. Company Details
    Table 41. Baxter International Inc. Business Overview
    Table 42. Baxter International Inc. Total Parenteral Nutrition (TPN) Solution Product
    Table 43. Baxter International Inc. Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022) & (US$ Million)
    Table 44. Baxter International Inc. Recent Development
    Table 45. Kelun Pharma Company Details
    Table 46. Kelun Pharma Business Overview
    Table 47. Kelun Pharma Total Parenteral Nutrition (TPN) Solution Product
    Table 48. Kelun Pharma Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022) & (US$ Million)
    Table 49. Kelun Pharma Recent Development
    Table 50. B. Braun Company Details
    Table 51. B. Braun Business Overview
    Table 52. B. Braun Total Parenteral Nutrition (TPN) Solution Product
    Table 53. B. Braun Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022) & (US$ Million)
    Table 54. B. Braun Recent Development
    Table 55. Fresenius Company Details
    Table 56. Fresenius Business Overview
    Table 57. Fresenius Total Parenteral Nutrition (TPN) Solution Product
    Table 58. Fresenius Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022) & (US$ Million)
    Table 59. Fresenius Recent Development
    Table 60. Teva Pharmaceutical Industries Company Details
    Table 61. Teva Pharmaceutical Industries Business Overview
    Table 62. Teva Pharmaceutical Industries Total Parenteral Nutrition (TPN) Solution Product
    Table 63. Teva Pharmaceutical Industries Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022) & (US$ Million)
    Table 64. Teva Pharmaceutical Industries Recent Development
    Table 65. Pfizer (Hospira) Company Details
    Table 66. Pfizer (Hospira) Business Overview
    Table 67. Pfizer (Hospira) Total Parenteral Nutrition (TPN) Solution Product
    Table 68. Pfizer (Hospira) Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022) & (US$ Million)
    Table 69. Pfizer (Hospira) Recent Development
    Table 70. Ostuka Pharmaceutical Company Details
    Table 71. Ostuka Pharmaceutical Business Overview
    Table 72. Ostuka Pharmaceutical Total Parenteral Nutrition (TPN) Solution Product
    Table 73. Ostuka Pharmaceutical Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022) & (US$ Million)
    Table 74. Ostuka Pharmaceutical Recent Development
    Table 75. Laboratorios Biogalenic Company Details
    Table 76. Laboratorios Biogalenic Business Overview
    Table 77. Laboratorios Biogalenic Total Parenteral Nutrition (TPN) Solution Product
    Table 78. Laboratorios Biogalenic Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022) & (US$ Million)
    Table 79. Laboratorios Biogalenic Recent Development
    Table 80. Laboratorios Finlay Company Details
    Table 81. Laboratorios Finlay Business Overview
    Table 82. Laboratorios Finlay Total Parenteral Nutrition (TPN) Solution Product
    Table 83. Laboratorios Finlay Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022) & (US$ Million)
    Table 84. Laboratorios Finlay Recent Development
    Table 85. Grifols International Company Details
    Table 86. Grifols International Business Overview
    Table 87. Grifols International Total Parenteral Nutrition (TPN) Solution Product
    Table 88. Grifols International Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022) & (US$ Million)
    Table 89. Grifols International Recent Development
    Table 90. Fresenius Kabi Company Details
    Table 91. Fresenius Kabi Business Overview
    Table 92. Fresenius Kabi Total Parenteral Nutrition (TPN) Solution Product
    Table 93. Fresenius Kabi Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022) & (US$ Million)
    Table 94. Fresenius Kabi Recent Development
    Table 95. Sichuan Kelun Pharmaceutical Company Details
    Table 96. Sichuan Kelun Pharmaceutical Business Overview
    Table 97. Sichuan Kelun Pharmaceutical Total Parenteral Nutrition (TPN) Solution Product
    Table 98. Sichuan Kelun Pharmaceutical Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022) & (US$ Million)
    Table 99. Sichuan Kelun Pharmaceutical Recent Development
    Table 100. Research Programs/Design for This Report
    Table 101. Key Data Information from Secondary Sources
    Table 102. Key Data Information from Primary Sources
List of Figures
    Figure 1. Total Parenteral Nutrition (TPN) Solution Product Picture
    Figure 2. Global Total Parenteral Nutrition (TPN) Solution Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Total Parenteral Nutrition (TPN) Solution Market Size 2017-2028 (US$ Million)
    Figure 4. United States Total Parenteral Nutrition (TPN) Solution Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Total Parenteral Nutrition (TPN) Solution Market Size 2017-2028 (US$ Million)
    Figure 6. United States Total Parenteral Nutrition (TPN) Solution Market Share in Global 2017-2028
    Figure 7. Total Parenteral Nutrition (TPN) Solution Report Years Considered
    Figure 8. Product Picture of Amino Acid-Dextrose Solution
    Figure 9. Product Picture of Lipid Emulsions Solution
    Figure 10. Global Total Parenteral Nutrition (TPN) Solution Market Share by Type in 2022 & 2028
    Figure 11. Global Total Parenteral Nutrition (TPN) Solution Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Total Parenteral Nutrition (TPN) Solution Market Share by Type (2017-2028)
    Figure 13. United States Total Parenteral Nutrition (TPN) Solution Market Share by Type in 2022 & 2028
    Figure 14. United States Total Parenteral Nutrition (TPN) Solution Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Total Parenteral Nutrition (TPN) Solution Market Share by Type (2017-2028)
    Figure 16. Product Picture of Hospital
    Figure 17. Product Picture of Home
    Figure 18. Global Total Parenteral Nutrition (TPN) Solution Market Share by Application in 2022 & 2028
    Figure 19. Global Total Parenteral Nutrition (TPN) Solution Market Size by Application (2017-2028) & (US$ Million)
    Figure 20. Global Total Parenteral Nutrition (TPN) Solution Market Share by Application (2017-2028)
    Figure 21. United States Total Parenteral Nutrition (TPN) Solution Market Share by Application in 2022 & 2028
    Figure 22. United States Total Parenteral Nutrition (TPN) Solution Market Size by Application (2017-2028) & (US$ Million)
    Figure 23. United States Total Parenteral Nutrition (TPN) Solution Market Share by Application (2017-2028)
    Figure 24. North America Total Parenteral Nutrition (TPN) Solution Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 25. United States Total Parenteral Nutrition (TPN) Solution Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 26. Canada Total Parenteral Nutrition (TPN) Solution Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 27. Europe Total Parenteral Nutrition (TPN) Solution Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 28. Germany Total Parenteral Nutrition (TPN) Solution Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. France Total Parenteral Nutrition (TPN) Solution Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. U.K. Total Parenteral Nutrition (TPN) Solution Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Italy Total Parenteral Nutrition (TPN) Solution Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Russia Total Parenteral Nutrition (TPN) Solution Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Total Parenteral Nutrition (TPN) Solution Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 34. China Total Parenteral Nutrition (TPN) Solution Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Japan Total Parenteral Nutrition (TPN) Solution Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. South Korea Total Parenteral Nutrition (TPN) Solution Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. India Total Parenteral Nutrition (TPN) Solution Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Australia Total Parenteral Nutrition (TPN) Solution Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. China Taiwan Total Parenteral Nutrition (TPN) Solution Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Indonesia Total Parenteral Nutrition (TPN) Solution Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Thailand Total Parenteral Nutrition (TPN) Solution Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Malaysia Total Parenteral Nutrition (TPN) Solution Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Latin America Total Parenteral Nutrition (TPN) Solution Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 44. Mexico Total Parenteral Nutrition (TPN) Solution Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Brazil Total Parenteral Nutrition (TPN) Solution Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Argentina Total Parenteral Nutrition (TPN) Solution Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Colombia Total Parenteral Nutrition (TPN) Solution Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa Total Parenteral Nutrition (TPN) Solution Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 49. Turkey Total Parenteral Nutrition (TPN) Solution Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Saudi Arabia Total Parenteral Nutrition (TPN) Solution Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. UAE Total Parenteral Nutrition (TPN) Solution Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Eurofarma Revenue Growth Rate in Total Parenteral Nutrition (TPN) Solution Business (2017-2022)
    Figure 53. Corporacion De Laboratorios Farmaceuticos Revenue Growth Rate in Total Parenteral Nutrition (TPN) Solution Business (2017-2022)
    Figure 54. Baxter International Inc. Revenue Growth Rate in Total Parenteral Nutrition (TPN) Solution Business (2017-2022)
    Figure 55. Kelun Pharma Revenue Growth Rate in Total Parenteral Nutrition (TPN) Solution Business (2017-2022)
    Figure 56. B. Braun Revenue Growth Rate in Total Parenteral Nutrition (TPN) Solution Business (2017-2022)
    Figure 57. Fresenius Revenue Growth Rate in Total Parenteral Nutrition (TPN) Solution Business (2017-2022)
    Figure 58. Teva Pharmaceutical Industries Revenue Growth Rate in Total Parenteral Nutrition (TPN) Solution Business (2017-2022)
    Figure 59. Pfizer (Hospira) Revenue Growth Rate in Total Parenteral Nutrition (TPN) Solution Business (2017-2022)
    Figure 60. Ostuka Pharmaceutical Revenue Growth Rate in Total Parenteral Nutrition (TPN) Solution Business (2017-2022)
    Figure 61. Laboratorios Biogalenic Revenue Growth Rate in Total Parenteral Nutrition (TPN) Solution Business (2017-2022)
    Figure 62. Laboratorios Finlay Revenue Growth Rate in Total Parenteral Nutrition (TPN) Solution Business (2017-2022)
    Figure 63. Grifols International Revenue Growth Rate in Total Parenteral Nutrition (TPN) Solution Business (2017-2022)
    Figure 64. Fresenius Kabi Revenue Growth Rate in Total Parenteral Nutrition (TPN) Solution Business (2017-2022)
    Figure 65. Sichuan Kelun Pharmaceutical Revenue Growth Rate in Total Parenteral Nutrition (TPN) Solution Business (2017-2022)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed

Market Analysis and Insights: Global and United States Total Parenteral Nutrition (TPN) Solution Market
This report focuses on global and United States Total Parenteral Nutrition (TPN) Solution market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Total Parenteral Nutrition (TPN) Solution market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Amino Acid-Dextrose Solution accounting for % of the Total Parenteral Nutrition (TPN) Solution global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospital was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Total Parenteral Nutrition (TPN) Solution market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period 2022-2028.

Global Total Parenteral Nutrition (TPN) Solution Scope and Market Size
Total Parenteral Nutrition (TPN) Solution market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Total Parenteral Nutrition (TPN) Solution market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Total Parenteral Nutrition (TPN) Solution market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    Amino Acid-Dextrose Solution
    Lipid Emulsions Solution

Segment by Application
    Hospital
    Home

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
        Colombia
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Eurofarma
    Corporacion De Laboratorios Farmaceuticos
    Baxter International Inc.
    Kelun Pharma
    B. Braun
    Fresenius
    Teva Pharmaceutical Industries
    Pfizer (Hospira)
    Ostuka Pharmaceutical
    Laboratorios Biogalenic
    Laboratorios Finlay
    Grifols International
    Fresenius Kabi
    Sichuan Kelun Pharmaceutical